TherapeuticsMD (TXMD) Non-Current Assets (2010 - 2026)

TherapeuticsMD has reported Non-Current Assets for 17 years, with the latest figure at $22.3 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 13.24% year-over-year to $22.3 million; the trailing twelve-month figure through Mar 2026 stood at $94.7 million (down 12.27% YoY), and the FY2025 full-year result was $23.2 million, down 12.62% from the prior year.
• Non-Current Assets for Q1 2026 stood at $22.3 million, down from $23.2 million in the prior quarter.
• The five-year high for Non-Current Assets was $49.0 million in Q1 2022, with the low at $22.3 million in Q1 2026.
• Historically, Non-Current Assets has averaged $32.1 million across 5 years, with a median of $30.6 million in 2024.
• The largest YoY upside for Non-Current Assets was 6.33% in 2022 against a maximum downside of 29.79% in 2022.
• TherapeuticsMD's Non-Current Assets stood at $35.1 million in 2022, then decreased by 10.24% to $31.5 million in 2023, then slipped by 15.71% to $26.6 million in 2024, then retreated by 12.62% to $23.2 million in 2025, then slipped by 3.85% to $22.3 million in 2026.
• The last three Non-Current Assets figures came in at $22.3 million (Q1 2026), $23.2 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.